Outcomes after laser enucleation of the prostate with and without significant storage symptoms

IF 3.7 2区 医学 Q1 UROLOGY & NEPHROLOGY
Cristina Cano Garcia, Maria Welte, Maximilian Filzmayer, Pia Bongardt, Fiona Schlesinger, Ivan Nikolov, Zhe Tian, Pierre I. Karakiewicz, Luis A. Kluth, Philipp Mandel, Felix K. H. Chun, Marina Kosiba, Andreas Becker
{"title":"Outcomes after laser enucleation of the prostate with and without significant storage symptoms","authors":"Cristina Cano Garcia,&nbsp;Maria Welte,&nbsp;Maximilian Filzmayer,&nbsp;Pia Bongardt,&nbsp;Fiona Schlesinger,&nbsp;Ivan Nikolov,&nbsp;Zhe Tian,&nbsp;Pierre I. Karakiewicz,&nbsp;Luis A. Kluth,&nbsp;Philipp Mandel,&nbsp;Felix K. H. Chun,&nbsp;Marina Kosiba,&nbsp;Andreas Becker","doi":"10.1111/bju.16495","DOIUrl":null,"url":null,"abstract":"<div>\n \n <section>\n \n <h3> Objective</h3>\n \n <p>To test for differences in recovery of lower urinary tract symptoms (LUTS) between patients with storage-positive vs -negative symptoms after laser enucleation of the prostate (LEP).</p>\n </section>\n \n <section>\n \n <h3> Patients and methods</h3>\n \n <p>Consecutive storage-positive (severe storage symptoms, International Prostate Symptom Score [IPSS] storage subscore &gt;8) vs storage-negative patients treated with LEP (November 2017–September 2022) within our tertiary-care database were identified. Mixed linear models tested for changes in IPSS and quality of life (QoL) at 1, 3 and 12 months after LEP. Multiple linear regression models tested for LUTS and QoL recovery risk factors at 1, 3 and 12 months.</p>\n </section>\n \n <section>\n \n <h3> Results</h3>\n \n <p>Of 291 study patients, 180 (62%) had storage-positive symptoms. There were no differences between storage-positive and -negative patients in mean adjusted total IPSS, IPSS-storage, IPSS-voiding and QoL at 12 months after LEP. In multiple linear regression models, storage-positive status was identified as a risk factor for higher IPSS at 1 month (β coefficient 2.98, <i>P</i> = 0.004) and 3 months (β coefficient 2.24, <i>P</i> = 0.04), as well as for more unfavourable QoL at 1 month (β coefficient 0.74, <i>P</i> = 0.006) and 3 months (β coefficient 0.73, <i>P</i> = 0.004) after LEP. Conversely, at 12 months there were no differences between storage-positive vs -negative patients.</p>\n </section>\n \n <section>\n \n <h3> Conclusion</h3>\n \n <p>Storage-positive patients appear to experience similar long-term benefits from LEP compared to storage-negative patients. However, significant storage symptoms are associated with higher total IPSS and less favourable QoL at 1 and 3 months after LEP. These findings advocate for the consideration of LEP also in storage-positive cases with the need for thorough patient education especially in the initial post-LEP period.</p>\n </section>\n </div>","PeriodicalId":8985,"journal":{"name":"BJU International","volume":"134 6","pages":"945-952"},"PeriodicalIF":3.7000,"publicationDate":"2024-08-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/bju.16495","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BJU International","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/bju.16495","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"UROLOGY & NEPHROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Objective

To test for differences in recovery of lower urinary tract symptoms (LUTS) between patients with storage-positive vs -negative symptoms after laser enucleation of the prostate (LEP).

Patients and methods

Consecutive storage-positive (severe storage symptoms, International Prostate Symptom Score [IPSS] storage subscore >8) vs storage-negative patients treated with LEP (November 2017–September 2022) within our tertiary-care database were identified. Mixed linear models tested for changes in IPSS and quality of life (QoL) at 1, 3 and 12 months after LEP. Multiple linear regression models tested for LUTS and QoL recovery risk factors at 1, 3 and 12 months.

Results

Of 291 study patients, 180 (62%) had storage-positive symptoms. There were no differences between storage-positive and -negative patients in mean adjusted total IPSS, IPSS-storage, IPSS-voiding and QoL at 12 months after LEP. In multiple linear regression models, storage-positive status was identified as a risk factor for higher IPSS at 1 month (β coefficient 2.98, P = 0.004) and 3 months (β coefficient 2.24, P = 0.04), as well as for more unfavourable QoL at 1 month (β coefficient 0.74, P = 0.006) and 3 months (β coefficient 0.73, P = 0.004) after LEP. Conversely, at 12 months there were no differences between storage-positive vs -negative patients.

Conclusion

Storage-positive patients appear to experience similar long-term benefits from LEP compared to storage-negative patients. However, significant storage symptoms are associated with higher total IPSS and less favourable QoL at 1 and 3 months after LEP. These findings advocate for the consideration of LEP also in storage-positive cases with the need for thorough patient education especially in the initial post-LEP period.

Abstract Image

前列腺激光去核术后有无明显贮存症状的结果。
目的检验前列腺激光去核术(LEP)后储尿阳性患者与储尿阴性患者在下尿路症状(LUTS)恢复方面的差异:在我们的三级医疗数据库中,确定了连续的储尿阳性(严重储尿症状,国际前列腺症状评分[IPSS]储尿子分值>8)与储尿阴性患者接受LEP治疗的情况(2017年11月至2022年9月)。混合线性模型检测了LEP后1、3和12个月时IPSS和生活质量(QoL)的变化。多元线性回归模型检测了 1、3 和 12 个月后 LUTS 和 QoL 恢复的风险因素:在 291 名研究患者中,180 人(62%)有储藏阳性症状。LEP 术后 12 个月时,在调整后的总 IPSS、IPSS-储量、IPSS-排空和 QoL 平均值方面,储量阳性和阴性患者之间没有差异。在多元线性回归模型中,储量阳性是 LEP 后 1 个月(β 系数 2.98,P = 0.004)和 3 个月(β 系数 2.24,P = 0.04)IPSS 较高以及 1 个月(β 系数 0.74,P = 0.006)和 3 个月(β 系数 0.73,P = 0.004)QoL 较差的危险因素。相反,在 12 个月时,储存阳性患者与储存阴性患者之间没有差异:结论:与蓄积阴性患者相比,蓄积阳性患者似乎从 LEP 中获得了相似的长期益处。然而,在 LEP 术后 1 个月和 3 个月,明显的蓄积症状与较高的总 IPSS 值和较差的 QoL 值相关。这些研究结果主张对储藏阳性病例也应考虑 LEP,同时需要对患者进行全面的教育,尤其是在 LEP 后的初期。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
BJU International
BJU International 医学-泌尿学与肾脏学
CiteScore
9.10
自引率
4.40%
发文量
262
审稿时长
1 months
期刊介绍: BJUI is one of the most highly respected medical journals in the world, with a truly international range of published papers and appeal. Every issue gives invaluable practical information in the form of original articles, reviews, comments, surgical education articles, and translational science articles in the field of urology. BJUI employs topical sections, and is in full colour, making it easier to browse or search for something specific.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信